Bonyf N.V (MLBON) | Financial Analysis & Statements
Bonyf N.V. | Small-cap | Healthcare
Bonyf N.V. | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
281.5K
Gross Profit
22.6K
8.02%
Operating Income
-34.7K
-12.33%
Net Income
-36.5K
-12.97%
Balance Sheet Metrics
Total Assets
3.3M
Total Liabilities
696.5K
Shareholders Equity
2.6M
Debt to Equity
0.26
Cash Flow Metrics
Operating Cash Flow
57.0M
Free Cash Flow
57.0M
Revenue & Profitability Trend
Bonyf N.V Income Statement From 2019 to 2024
| Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 281.5K | 309.4K | 277.4K | 2.4M | 3.2M |
| Cost of Goods Sold | 258.9K | 283.0K | 267.3K | 715.2K | 1.0M |
| Gross Profit | 22.6K | 26.4K | 10.0K | 1.7M | 2.2M |
| Operating Expenses | 3.1K | 10.6K | 221.5K | 642.4K | 697.2K |
| Operating Income | -34.7K | -39.9K | -317.5K | -48.8K | 226.0K |
| Pre-tax Income | -36.5K | -1.0M | -3.3M | -67.1K | 193.5K |
| Income Tax | - | - | - | 3.1K | 2.8K |
| Net Income | -36.5K | -1.0M | -3.3M | -70.2K | 190.7K |
| EPS (Diluted) | - | - | -€5.64 | -€0.12 | €0.32 |
Income Statement Trend
Bonyf N.V Balance Sheet From 2019 to 2024
| Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 340.9K | 92.9K | 170.6K | 1.1M | 1.0M |
| Non-Current Assets | 3.0M | 3.0M | 4.0M | 302.7K | 350.6K |
| Total Assets | 3.3M | 3.1M | 4.2M | 1.4M | 1.4M |
| Liabilities | |||||
| Current Liabilities | 674.7K | 411.9K | 445.0K | 258.9K | 256.3K |
| Non-Current Liabilities | 21.8K | 0 | 0 | 840.6K | 785.0K |
| Total Liabilities | 696.5K | 411.9K | 445.0K | 1.1M | 1.0M |
| Equity | |||||
| Total Shareholders Equity | 2.6M | 2.7M | 3.7M | 280.1K | 345.5K |
Balance Sheet Composition
Bonyf N.V Cash Flow Statement From 2020 to 2020
| Metric | 2020 |
|---|---|
| Operating Activities | |
| Net Income | - |
| Operating Cash Flow | 57.0M |
| Investing Activities | |
| Capital Expenditures | - |
| Investing Cash Flow | - |
| Financing Activities | |
| Dividends Paid | - |
| Financing Cash Flow | - |
| Free Cash Flow | 57.0M |
Cash Flow Trend
Bonyf N.V Key Financial Ratios
Valuation Ratios
Price to Book
18.85
Price to Sales
26.45
Profitability Ratios
Profit Margin
8.54%
Operating Margin
-12.90%
Return on Equity
-38.97%
Return on Assets
-33.78%
Financial Health
Current Ratio
4.92
Debt to Equity
0.00
Per Share Data
EPS (TTM)
-€1.78
Book Value per Share
€0.74
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| mlbon | 8.2M | - | 18.85 | -38.97% | 8.54% | 0.00 |
| Amplitude Surgical | 295.0M | 307.50 | 3.12 | 1.15% | 1.00% | 126.32 |
| Crossject S.A | 80.5M | - | - | 478.68% | 0.00% | -7.88 |
| Visiomed Group SA | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
| Spineway S.A | 3.9M | 0.02 | 0.07 | -17.85% | -30.35% | 7.50 |
| I.Ceram S.A | 155.7K | 9.88 | 0.46 | -124.00% | -170.02% | 476.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.